drugset / Trial / NCT02868801
Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the Efficacy and safety of pregabalin sustained release tablet versus placebo for postherpetic neuralgia.
Timeline
- Start
- 2015-03
- Primary completion
- 2017-06
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 330 mg | Oral |
| Subject | Pregabalin | Small molecule | 660 mg | Oral |